TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.20
−1.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.94x
- P/E 2027E
- 11.58x
- P/E 2028E
- —
- P/S forward
- 0.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.94x
- Price / sales
- 7.79x
- Price / cash flow
- 8.16x
Enterprise value
- Enterprise value
- $21.8M
- EV / sales
- 6.68x
- EV / EBITDA
- -5.20x
- EV / EBIT
- -5.67x
- Market cap
- $25.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026